翻訳と辞書 |
Preotact
Preotact is a pharmaceutical form of parathyroid hormone (H05AA03) manufactured using a strain of Escherichia coli modified by recombinant DNA technology. Preotact is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated. Preotact is marketed in Europe by Nycomed. PreosTM is a registered trade mark owned by NPS Pharmaceuticals, Inc. The name PreosTM and the New Drug Application is pending approval by the U.S. Food and Drug Administration (FDA). == Clinical indication/use == Preotact is approved by the European Medicines Agency for the treatment of osteoporosis in postmenopausal women at high risk of fractures. US approval is pending with the FDA.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Preotact」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|